malaymail7h
When beauticians play doctor: What’s really inside ‘IV drips for white skin’ and other aesthetic fillers
The booming aesthetic industry was projected to grow over US$999 million (about RM4.378 billion) by 2026, according to then ...
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Held biosimilar advisory meeting with FDA in Q3 2024, and aligned on next steps for a 351(k) regulatory pathway to approval for ABP-450 (prabotulinumtoxinA) as a biosimilar utilizing BOTOX® (onabotuli ...